| Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease MA Nalls, N Pankratz, CM Lill, CB Do, DG Hernandez, M Saad, ... Nature genetics 46 (9), 989-993, 2014 | 2068 | 2014 |
| The release and trans-synaptic transmission of Tau via exosomes Y Wang, V Balaji, S Kaniyappan, L Krüger, S Irsen, K Tepper, ... Molecular neurodegeneration 12, 1-25, 2017 | 672 | 2017 |
| Technology in Parkinson's disease: challenges and opportunities AJ Espay, P Bonato, FB Nahab, W Maetzler, JM Dean, J Klucken, ... Movement Disorders 31 (9), 1272-1282, 2016 | 660 | 2016 |
| Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy GU Höglinger, NM Melhem, DW Dickson, PMA Sleiman, LS Wang, L Klei, ... Nature genetics 43 (7), 699-705, 2011 | 651 | 2011 |
| A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies MA Nalls, R Duran, G Lopez, M Kurzawa-Akanbi, IG McKeith, ... JAMA neurology 70 (6), 727-735, 2013 | 504 | 2013 |
| Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases (vol 91, pg 56, 2016) M Bacioglu, L Maia, O F. Preische, J Schelle, A Apel, S Kaeser, ... Neuron 91 (2), 494-496, 2016 | 451* | 2016 |
| Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1/Parkin-dependent mitophagy S Lesage, V Drouet, E Majounie, V Deramecourt, M Jacoupy, A Nicolas, ... The American Journal of Human Genetics 98 (3), 500-513, 2016 | 439 | 2016 |
| Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease LA Robak, IE Jansen, J Van Rooij, AG Uitterlinden, R Kraaij, J Jankovic, ... Brain 140 (12), 3191-3203, 2017 | 417 | 2017 |
| Progression of Parkinson's disease in the clinical phase: potential markers W Maetzler, I Liepelt, D Berg The Lancet Neurology 8 (12), 1158-1171, 2009 | 415 | 2009 |
| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 406 | 2013 |
| Quantitative wearable sensors for objective assessment of Parkinson's disease W Maetzler, J Domingos, K Srulijes, JJ Ferreira, BR Bloem Movement Disorders 28 (12), 1628-1637, 2013 | 401 | 2013 |
| BDNF serum and CSF concentrations in Alzheimer’s disease, normal pressure hydrocephalus and healthy controls C Laske, E Stransky, T Leyhe, GW Eschweiler, W Maetzler, A Wittorf, ... Journal of psychiatric research 41 (5), 387-394, 2007 | 354 | 2007 |
| A Pan‐European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats J van der Zee, I Gijselinck, L Dillen, T Van Langenhove, J Theuns, ... Human mutation 34 (2), 363-373, 2013 | 337 | 2013 |
| A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy E Tolosa, I Litvan, GU Höglinger, D Burn, A Lees, MV Andrés, ... Movement Disorders 29 (4), 470-478, 2014 | 332 | 2014 |
| Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption MC Cornelis, EM Byrne, T Esko, MA Nalls, A Ganna, N Paynter, ... Molecular psychiatry 20 (5), 647-656, 2015 | 302 | 2015 |
| GBA‐associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study K Brockmann, K Srulijes, S Pflederer, AK Hauser, C Schulte, W Maetzler, ... Movement Disorders 30 (3), 407-411, 2015 | 286 | 2015 |
| Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies J Bras, R Guerreiro, L Darwent, L Parkkinen, O Ansorge, V Escott-Price, ... Human molecular genetics 23 (23), 6139-6146, 2014 | 269 | 2014 |
| A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson’s disease C Godinho, J Domingos, G Cunha, AT Santos, RM Fernandes, D Abreu, ... Journal of neuroengineering and rehabilitation 13, 1-10, 2016 | 262 | 2016 |
| Long-term unsupervised mobility assessment in movement disorders E Warmerdam, JM Hausdorff, A Atrsaei, Y Zhou, A Mirelman, K Aminian, ... The Lancet Neurology 19 (5), 462-470, 2020 | 256 | 2020 |
| A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies AJ Espay, JM Hausdorff, Á Sánchez‐Ferro, J Klucken, A Merola, P Bonato, ... Movement Disorders 34 (5), 657-663, 2019 | 255 | 2019 |
